← back to search

Dirk Wilhelm

Technical University of Munich · DE
Area of research
Surgery · Oncology
Research interest
Research interests include Medicine, Oncology, Colorectal cancer, Computer science, Grading (engineering), and Microsatellite instability.
h-index
citations
207
works
14
NIH funding
primary concept
email

Recent publications

Comparative validation of surgical phase recognition, instrument keypoint estimation, and instrument instance segmentation in endoscopy: Results of the PhaKIR 2024 challenge
Medical Image Analysis 2026cited by 2position: middledoi
Comparative validation of surgical phase recognition, instrument keypoint estimation, and instrument instance segmentation in endoscopy: Results of the PhaKIR 2024 challenge
Medical Image Analysis 2026cited by 0position: middledoi
Modifiziertes Delphi-Verfahren zur Konsensfindung für die Konzeption eines bundesweiten Curriculums für minimalinvasive und roboterassistierte Chirurgie in Deutschland (GeRMIQ)
Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie 2024cited by 4position: middledoi
Development of an image-based Random Forest classifier for prediction of surgery duration of laparoscopic sigmoid resections
International Journal of Colorectal Disease 2024cited by 3position: middledoi
Deep Learning-based Artificial Intelligence in Audio based Analysis of Swallowing using Cervical Auscultation
Current Directions in Biomedical Engineering 2024cited by 1position: middledoi
Smoke Classification in Laparoscopic Cholecystectomy Videos Incorporating Spatio-temporal Information
Informatik aktuell 2024cited by 0position: middledoi
Surgomics: personalized prediction of morbidity, mortality and long-term outcome in surgery using machine learning on multimodal data
Surgical Endoscopy 2022cited by 25position: middledoi
pT3 colorectal cancer revisited: a multicentric study on the histological depth of invasion in more than 1000 pT3 carcinomas—proposal for a new pT3a/pT3b subclassification
British Journal of Cancer 2022cited by 14position: middledoi
Loss of CDX2 in colorectal cancer is associated with histopathologic subtypes and microsatellite instability but is prognostically inferior to hematoxylin–eosin-based morphologic parameters from the WHO classification
British Journal of Cancer 2021cited by 43position: middledoi
Morphology Matters
The American Journal of Surgical Pathology 2021cited by 40position: middledoi
Neuroendocrine Differentiation in Conventional Colorectal Adenocarcinomas: Incidental Finding or Prognostic Biomarker?
Cancers 2021cited by 20position: middledoi
Loss of SATB2 Occurs More Frequently Than CDX2 Loss in Colorectal Carcinoma and Identifies Particularly Aggressive Cancers in High-Risk Subgroups
Cancers 2021cited by 18position: middledoi
Cellular Dissociation Grading Based on the Parameters Tumor Budding and Cell Nest Size in Pretherapeutic Biopsy Specimens Allows for Prognostic Patient Stratification in Esophageal Squamous Cell Carcinoma Independent From Clinical Staging
The American Journal of Surgical Pathology 2019cited by 22position: middledoi
Post-neoadjuvant cellular dissociation grading based on tumour budding and cell nest size is associated with therapy response and survival in oesophageal squamous cell carcinoma
British Journal of Cancer 2019cited by 15position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Wilko Weichert · German Cancer Research Center7 papers (2019–2022)Moritz Jesinghaus · Laser Systems & Solutions of Europe (France)7 papers (2019–2022)Björn Konukiewitz · Technical University of Munich7 papers (2019–2022)Katja Steiger · Technical University of Munich6 papers (2019–2021)Sebastian Foersch · Helmholtz Institute Mainz5 papers (2021–2022)Maxime Schmitt · Technical University of Munich5 papers (2021–2022)Sebastian Lange · Heidelberg University4 papers (2019–2022)Corinna Lang · Technical University of Munich4 papers (2021–2021)Jutta Engel · Saarland University4 papers (2021–2022)Melanie Boxberg · Starnberg Hospital4 papers (2019–2021)Markus Tschurtschenthaler · German Cancer Research Center4 papers (2021–2022)Miguel G. Silva · TUM Klinikum3 papers (2021–2021)Paul Jank · University Hospital Frankfurt3 papers (2021–2022)Carsten Denkert · Frankfurt Cancer Institute3 papers (2021–2022)Nicole Pfarr · Technical University of Munich3 papers (2021–2021)Hubertus Feußner · Technical University of Munich3 papers (2024–2024)Helmut Friess · Klinikum rechts der Isar3 papers (2019–2021)Kathrin Halfter · Ludwig-Maximilians-Universität München3 papers (2021–2021)Stefan Münch · Sozialstiftung Bamberg2 papers (2019–2019)Stephanie E. Combs · Brooke Army Medical Center2 papers (2019–2019)